Cipher PharmaceuticalsCPHRF 96 Days Inventory is 338.61 as of Mar. 2026, which is 100% above its 10-year median of 169.48. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.30 (Fairly Valued). The stock has 5 warning signs investors should review. Among 918 Drug Manufacturers companies, Cipher Pharmaceuticals ranks worse than 79.08% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cipher Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cipher Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.66.
Cipher Pharmaceuticals (OTCPK:CPHRF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cipher Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cipher Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cipher Pharmaceuticals Days Inventory Related Terms
Cipher Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Cipher Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cipher Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cipher Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cipher Pharmaceuticals (CPHRF) has a Days Inventory of 338.61 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cipher Pharmaceuticals and its competitors. This is 100% above median its historical median of 169.48. Over the past decade, Cipher Pharmaceuticals' Days Inventory has ranged from 97.51 to 268.80. According to the industry distribution chart, Cipher Pharmaceuticals ranks #726 out of 918 companies in the Drug Manufacturers industry, placing it in the top 79.1%.
Is Cipher Pharmaceuticals' Days Inventory too high?
Cipher Pharmaceuticals' current Days Inventory of 338.61 is 100% above median its 10-year median of 169.48. Over the past 10 years, this metric has ranged from a low of 97.51 to a high of 268.80. The Drug Manufacturers industry median Days Inventory is 164.43. Cipher Pharmaceuticals' value of 338.61 is 105.9% above this industry median. Based on the distribution chart, Cipher Pharmaceuticals ranks #726 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cipher Pharmaceuticals ranks #726 out of 918 companies for Days Inventory. This places Cipher Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.43. Cipher Pharmaceuticals' value of 338.61 is 105.9% above this benchmark. Historically, Cipher Pharmaceuticals' own Days Inventory has ranged from 97.51 to 268.80 over the past decade. While the company's 10-year median is 169.48 vs. the industry median of 164.43, Cipher Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cipher Pharmaceuticals's current Days Inventory of 338.61 is 105.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cipher Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cipher Pharmaceuticals's current Days Inventory is 338.61, which is 100% above median its own 10-year median of 169.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.30, compared to a current price of $11.77 — trading 4.3% below its estimated fair value. The current Days Inventory is 338.61, which is 100% above median its 10-year median of 169.48 and 105.9% above the Drug Manufacturers industry median of 164.43. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current Days Inventory is 338.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?
Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued.
The current stock price of $11.77 is trading 4.3% below its estimated GF Value™ of $12.30.
GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.
Key valuation signals for CPHRF:
Days Inventory: 338.61 (100% above median its 10-year median of 169.48)
GF Value™: $12.30 vs. price of $11.77 (4.3% below fair value)
Industry Position: 105.9% above the Drug Manufacturers median (#726 of 918)
No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score
Get the complete analysis for CPHRF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPHRF has been successfully added to your 
